About Us

Publications

BMT CTN investigators have published >135 manuscripts, including >30 primary study results papers, in numerous peer-reviewed journals, including the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. Selected publications are summarized for dissemination to patients and the lay public.

Note: To find a complete list of Publications, please see listing here.

 

Found 7 results
Filters: Author is Khera, Nandita  [Clear All Filters]
2023
M. Juckett, Dandoy, C., DeFilipp, Z., Kindwall-Keller, T. L., Spellman, S. R., Ustun, C., Waldman, B. M., Weisdorf, D. J., Wood, W. A., Horowitz, M. M., Burns, L. J., and Khera, N., “How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?”, Blood Rev, p. 101079, 2023.
2022
B. K. Hamilton, Cutler, C., Divine, C., Juckett, M., LeMaistre, C., Stewart, S., Wilder, J., Horowitz, M., Khera, N., and Burns, L. J., “Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice.”, Transplant Cell Ther, vol. 28, no. 8, pp. 419-425, 2022.
2021
E. D. Warlick, Ustun, C., Andreescu, A., Bonagura, A. F., Brunner, A., Chandra, A. B., Foran, J. M., Juckett, M. B., Kindwall-Keller, T. L., Klimek, V. M., Pease, D. F., Steensma, D. P., Waldman, B. M., Horowitz, M. M., Burns, L. J., and Khera, N., “Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation.”, Cancer, vol. 127, no. 23, pp. 4339-4347, 2021.
2020
Z. DeFilipp, Burns, L. J., Jaglowski, S. M., Leppin, A. L., Pavletic, S., Waldman, B., Weisdorf, D. J., Wood, W. A., and Khera, N., “A New Standard in Graft-versus-Host Disease Prophylaxis? An Introduction to Blood and Marrow Transplant Clinical Trials Network 1703.”, Biol Blood Marrow Transplant, vol. 26, no. 12, pp. e305-e308, 2020.
2018
S. G. Holtan, DeFor, T. E., Panoskaltsis-Mortari, A., Khera, N., Levine, J. E., Flowers, M. E. D., Lee, S. J., Inamoto, Y., Chen, G. L., Mayer, S., Arora, M., Palmer, J., Cutler, C. S., Arai, S., Lazaryan, A., Newell, L. F., Jagasia, M. H., Pusic, I., Wood, W. A., Renteria, A. S., Yanik, G., Hogan, W. J., Hexner, E., Ayuk, F., Holler, E., Bunworasate, U., Efebera, Y. A., Ferrara, J. L. M., Pidala, J., Howard, A., Wu, J., Bolaños-Meade, J., Ho, V., Alousi, A., Blazar, B. R., Weisdorf, D. J., and MacMillan, M. L., “Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.”, Blood Adv, vol. 2, no. 15, pp. 1882-1888, 2018.
N. Khera, Mau, L. - W., Denzen, E. M., Meyer, C., Houg, K., Lee, S. J., Horowitz, M. M., and Burns, L. J., “Translation of Clinical Research into Practice: An Impact Assessment of the Results from the Blood and Marrow Transplant Clinical Trials Network Protocol 0201 on Unrelated Graft Source Utilization.”, Biol Blood Marrow Transplant, vol. 24, no. 11, pp. 2204-2210, 2018.
2015
N. Khera, Majhail, N. S., Brazauskas, R., Wang, Z., He, N., Aljurf, M. D., Akpek, G., Atsuta, Y., Beattie, S., Bredeson, C. N., Burns, L. J., Dalal, J. D., Freytes, C. O., Gupta, V., Inamoto, Y., Lazarus, H. M., LeMaistre, C. F., Steinberg, A., Szwajcer, D., Wingard, J. R., Wirk, B., Wood, W. A., Joffe, S., Hahn, T. E., Loberiza, F. R., Anasetti, C., Horowitz, M. M., and Lee, S. J., “Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.”, Biol Blood Marrow Transplant, vol. 21, no. 10, pp. 1815-22, 2015.